← Leaderboards
Kenneth R. Hande
Vanderbilt University
$7,422,199
Attributed
$8,656,861
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,656,861 · 4
By mechanism
K12$8,655,085 · 1
M01$1,776 · 3
Top collaborators
- Debra L Friedman4 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard B Kim$2,161,767
- Alfred L George$44,065,377
- Hassane S McHaourab$22,963,634
- Michelle G Craske$19,938,115
- Grant R. Wilkinson$1,933,364
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchOncologyHuman SubjectClinical TrialsRadiation OncologyResearch Project GrantsScientistProgramsSuccessMaster Of ScienceMedical OncologyMentorsBaseHematologyClinical OncologyDesignClinical Oncology Supplement (K12)FacultyPhysiciansSurgical OncologyLecturesMalignant NeoplasmsCareerTherapeutic Human Experimentation
Grant awards (22)
Vanderbilt Clinical Oncology Research Career Development Award$309,351
K12 · FY2015 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$209,064
K12 · FY2015 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$1,007,108
K12 · FY2014 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$943,802
K12 · FY2013 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$1,061,422
K12 · FY2012 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Award$519,910
K12 · FY2011 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Program$293,882
K12 · FY2010 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Program$569,627
K12 · FY2009 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Program$583,083
K12 · FY2008 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Program$749,965
K12 · FY2007 · CA · contact PI
Vanderbilt Clinical Oncology Research Career Development Program$391,745
K12 · FY2006 · CA · contact PI
Vanderbilt Clinical Oncology Res.Career Develop.Program$576,036
K12 · FY2004 · CA
Vanderbilt Clinical Oncology Res.Career Develop.Program$576,036
K12 · FY2003 · CA
Vanderbilt Clinical Oncology Res.Career Develop.Program$576,036
K12 · FY2002 · CA
MATRIX METALLOPROTEINASE INHIBITOR IN COMBINATION PACLITAXEL &CARBOPLATIN$0
M01 · FY2002 · RR
Vanderbilt Clinical Oncology Res.Career Develop.Program$288,018
K12 · FY2001 · CA
MATRIX METALLOPROTEINASE INHIBITOR IN COMBINATION PACLITAXEL &CARBOPLATIN$0
M01 · FY2001 · RR
MATRIX METALLOPROTEINASE INHIBITOR IN COMBINATION PACLITAXEL &CARBOPLATIN$0
M01 · FY2001 · RR
MATRIX METALLOPROTEINASE INHIBITOR IN COMBINATION PACLITAXEL &CARBOPLATIN$0
M01 · FY2001 · RR
5 DAY INFUSIONAL ETOPOSIDE PLUS MEGESTROL ACETATE--PHASE I CLINICAL/PHARMACOLOGY$592
M01 · FY2000 · RR
DOSE TOLERANCE STUDY, METALLOPROTEINASE INHIBITOR IN ADVANCED CANCER$592
M01 · FY2000 · RR
MATRIX METALLOPROTEINASE INHIBITOR IN COMBINATION PACLITAXEL &CARBOPLATIN$592
M01 · FY2000 · RR